ABSTRACT
Pelbagai konduit biologi semula jadi telah dikaji untuk menyambungkan semula kecederaan saraf periferi terutamanya yang bersaiz kritikal (lebih daripada 3 cm pada manusia). Rawatan piawai pada masa kini adalah pemindahan autograf, tetapi ia mempunyai beberapa kelemahan dalam amalan klinikal seperti kekurangan tisu penderma, morbiditi pada tapak penderma dan saiz tisu yang tidak sepadan. Tujuan kajian ini dijalankan adalah untuk mengkaji perkembangan konduit saraf menggunakan arteri tali pusat manusia yang telah dinyahsel dan disemai dengan sel saraf yang terbeza daripada sel stem mesenkima. Konduit arteri tali pusat manusia yang telah dinyahsel (n=3) seterusnya dikaji keberkesanannya menggunakan pewarnaan Hematoxylin dan Eosin (H&E) dan pewarnaan nukleus oleh
 DAPI 
INTRODUCTION
Insufficient functional restoration associated with peripheral nerve injury (PNI) has been a significant critical issue which sometime resulted to permanent disability. It was estimated that 50000 procedures were performed annually to repair damaged peripheral nerves at the cost of USD 7 billion per year (Liao et al. 2013) . Despite rapid clinical advancement, the treatment of PNI is still a challenge especially in critical gap (greater than 3 cm) (Kaizawa et al. 2017; Liao et al. 2013 ). This condition is worsened by the limited regeneration of peripheral nerve that depends on several factors including the length of injury, presence of neurotrophic factors and Schwann cells (Höke 2006) . The current gold standard procedure to bridge critical gap of PNI is the use of autologous nerve grafts, where the sural nerve is the most commonly used autograft (Ray et al. 2010) . Albeit its success in nerve regeneration and restoration of functional recovery is well documented, nerve autografting has several drawbacks including limited availability of donor graft, mismatch in size in clinical practice, additional surgery trauma at donor sites and associated functional loss of donor nerve (Gordon et al. 2003; Zhan et al. 2013) .
In the attempt to avoid the shortcomings of nerve autograft, researchers have focus their attention to the development of nerve conduits. Food and Drug Administration (FDA), has approved several nerve conduits made of natural polymers, NeuraGen, NeuroFlex, NeuroMatrix (Type 1 Collagen) and synthetic polymers, Neurotube (PGA) and Neurolac (caprolactone) (Deal et al. 2012; Kehoe et al. 2012) . A study reported that collagen coated PLGA nerve conduit seeded with neural differentiated mesenchymal stem cells is suitable for use as artificial nerve conduit (Hidayah et al. 2012; Sulong et al. 2014) . However, several disadvantages accompanying with synthetic nerve conduits have hindered its optimal functional recovery including chronic inflammation, acidic degradation by-product and rigidity mismatch (Deal et al. 2012; Liao et al. 2013) .
As an alternative, studies have been made on the use of natural biological nerve conduits for example vein, artery and fibroblast-made scaffold. The use of vein graft has shown effective results to treat nerve damage and enhance functional recovery in in vivo study (Hassan et al. 2012; Lokanathan et al. 2014) . However, several problems related with unmodified veins including; easily collapse and the presence of valves found to block axonal regeneration (Crouzier et al. 2009 ). On the other hand, the use of arterial graft seems to be gaining attention because of the few adding advantages, such as wall thickness, permeability and mechanical rigidity. Earlier study reported that artery conduit seeded with mesenchymal stem cells enhanced significantly axonal regeneration and prevented muscular atrophy (Liao et al. 2013) . Sun et al. (2011) reported that the use of decellularized artery conduit seeded with differentiated adipose derive stem cell resulted in better nerve regeneration and functional recovery. Apparently, human umbilical cord (HUC) artery might represent a good source as a nerve conduit as it is easily obtainable, simply isolated and lack branches (Mallis et al. 2014) . The HUC collected from health centres were redundant and often disposed as biological samples.
The use of allograft might provoke immunological response and the recipients should be under immunosuppressive drugs for a certain time. This issue can be avoidable by decellularization process, where this process removes native cells, residual blood and other soluble components leaving the extracellular matrix (ECM) that remained intact (Mallis et al. 2014; Quint et al. 2011; Tuan-Mu et al. 2014) . Besides, decellularized blood vessels maintained their three dimensional structure and reduce immunogenicity (Rodríguez-Rodríguez et al. 2017) . Furthermore, decellularized materials can be seeded with various cells and supplied with growth factors to mimic native tissue and consequently generate functional tissue (Gui et al. 2009 ).
On the other hand, the medicinal use of Centella asiatica (L.) or is also known as pegaga in Malaysia, Brahmi in Unani medicines, Mandookaparni in Ayurveda, Gotu Kola or Indian Pennywort in the western world (Jamil et al. 2007) , has been long documented in the previous studies. An accumulating evidence has demonstrated that this herbal medicine has neuroprotective and neuroregenerative properties (Lokanathan et al. 2016; Omar et al. 2011) . A study found that the bioactive compound present in C. asiatica fresh leaf juice has neuronal dendritic growth stimulating property, which act as neuronal basis for enhancing learning and memory (Mohandas et al. 2009 ). Another study showed that the treatment of C. asiatica ethanolic extract in rats demonstrated more rapid functional recovery and increased axonal regeneration, indicating that the axons grew at a faster rate, pointed out its neuroregenerative properties (Soumyanath et al. 2005) . These remedial values were believed to have been largely contributed by its bioactive components namely asiatic acid, madecassic acid, asiaticoside and madecassoside (Puttarak et al. 2016) .
The beneficial use of C. asiatica is not limited to just neural properties, this plant has several other advantages including on wound healing of skin, oxidative stress, anti-inflammatory, anti-depressant, sedative, gastric ulcer, memory-enhancing, anti-diabetic, cardioprotective, hepatoprotective and immunomodulation (Nurlaily et al. 2012; Ruszymah et al. 2012; Said 2009; Somboonwong et al. 2012; Tiwari et al. 2011) . Despite its good values, C. asiatica however exert some negative effects in terms of antifertility in male mice and anti-proliferative activities on cells (Mohd Heikal et al. 2014; Noor et al. 2004) . Thus, it is important to determine the optimal concentration of C. asiatica in order to gain its fully benefit.
Our in vitro study has confirmed that minimal dose of C. asiatica (400 μg/mL) has the capacity to differentiate human Wharton's Jelly mesenchymal stem cells into Schwann cells or other neural lineage cells (Norazzila et al. 2018 (Norazzila et al. , 2017 . Thus, the focus of this study was to develop decellularized human umbilical cord artery seeded with 400 μg/mL C. asiatica induced -neurodifferentiated human MSCs (ndMSCs) as an alternative nerve conduit for peripheral nerve injury.
MATERIALS AND METHODS

DECELLULARIZATION OF THE HUMAN UMBILICAL CORD ARTERY
This study was conducted at Universiti Kebangsaan Malaysia Medical Centre, Malaysia. All samples were collected with informed consent from patients and approved by Research Ethics Committee of Universiti Kebangsaan Malaysia (UKM) (no. FF-2017-175) . Human umbilical cord (HUC) samples (n=3) were obtained from healthy patients undergoing full term elective caesarean delivery. After collection, the HUC were rinsed several times with sterile Dulbecco's phosphate buffer saline (DPBS) (Sigma Aldrich, USA) to wash any bloodstains. The HUC samples were dissected and stripped off the arteries and vein. The Wharton's jelly part was kept for mesenchymal stem cells isolation. The decellularization process of the HUC arteries was done based on previously published protocol (Sun et al. 2011 ). After cleaning them off blood and connective tissue, the arteries were rinsed in sterile ice-cold saline. Then, they were decellularized with 0.025% trypsin-ethylenediaminetetraacetic acid (EDTA) (Sigma Aldrich, USA) in DPBS for 1 h, deionized distilled water (ddH2O) for 2 h, 1% detergent Triton X-100 (Sigma Aldrich, USA) in DPBS for 4 h, ddH2O for 1 h and 1% sodium dodecyl sulfate (SDS) (Sigma Aldrich, USA) in DPBS for 4 h. All procedures were performed under sterile conditions with continuous shaking at 37°C. The decellularized HUC arteries were then sterilized with 70% alcohol (SYSTERM, Malaysia) (3 × 15 min each), cut approximately 2 cm each and analysed using Hematoxylin & Eosin (H&E) (Richard-Allan Scientific, USA) staining and nuclei counter-staining with DAPI (Invitrogen, USA).
HEMATOXYLIN AND EOSIN (H&E) STAINING AND NUCLEI COUNTER-STAINING WITH DAPI (4',6-DIAMIDINO-2-PHENYLINDOLE) OF THE DECELLULARIZED HUC ARTERY
The decellularized and native arteries (control) were fixed with 10% formalin (Leica Biosystems, USA) for 24 h. The arteries were then rinsed with DPBS and processed using a series of chemicals, 50% and 70% alcohol (MERCK, Germany) (1 h each), 95% alcohol (1.5 h), absolute alcohol (3 × 1 h, 1.5 h and 1.5 h), equal part alcohol:toluene (1.5 h), toluene (3 × 1 h, 1.5 h and 1.5 h) and paraffin wax (2 × 2 h each). Then, tissues were embedded using paraffin wax for histological analysis. Tissue sections of 2-5 μm thin were cut using a microtome (Leica, Germany). The tissue sections were then dewaxed and dehydrated with a series of chemicals; xylene (J.T. Baker, USA) (3 × 5 min each) and alcohol (100%, 95% and 70%) (3 min each) followed by Hematoxylin staining (10 min) and Eosin staining (4 min). Lastly, the tissue sections were rehydrated with alcohol (95% and 100%) (3 min each) and xylene (3 × 5 min each). The tissue sections were mounted using mounting solution and observed under light microscope (OLYMPUS, CH30). For nuclei counterstaining with DAPI, after dehydration, tissue sections were permeabilized with 0.5% Triton X-100 for 20 min and incubated with DAPI (1/15000) for 40 min in the dark at room temperature. Next, tissues sections were mounted and observed under fluorescence microscope (Nikon, ECLIPSE Tἰ).
MEASUREMENT OF LENGTH OF DECELLULARIZED HUC ARTERY 1.5 cm of HUC arteries conduit was put in low-glucose Dulbecco's modified Eagle medium (DMEM-LG) (Gibco, USA) complete medium (containing 10% fetal bovine serum (FBS) (Gibco, USA), 1% Glutamax (Gibco, USA) and 1% antibiotic-antimycotic (Gibco, USA) at 37°C in humidified 5% CO 2 incubator (New Brunswick Galaxy® 170 Series, Eppendorf, USA) and the length was measured up every 2 weeks until 12 weeks.
ISOLATION AND PROPAGATION OF HUMAN WHARTON'S JELLY MESENCHYMAL STEM CELLS (hWJMSCs)
The human Wharton's Jelly samples were processed within 3 h of collection as prescribed in the previous study (Lim et al. 2016) . The Wharton's Jelly was minced and digested with 0.6% Collagenase Type 1 (Worthington, USA) in incubator shaker (250 rpm) at 37°C for 2 h. After complete digestion, the digested tissue was centrifuged at 5000 rpm for 5 min to obtain cell pellet. The cell pellet was washed with DPBS and subjected for another centrifugation. Then, the cell pellet was resuspended in DMEM-LG complete medium and cultured in T-25 cm² culture flask (Corning, USA) at 37°C in humidified 5% CO 2 incubator for expansion. Culture medium was changed every 3 days. Once it reached 80% confluency, it was detached using 0.05% trypsin and expanded into new flasks at a density of 5 × 10³ cells/cm². To ensure the consistency, passage 3 cells were used throughout the experiment.
NEURODIFFERENTIATION OF MSCS USING 400 ΜG/ML C. ASIATICA
The differentiation of hWJMSCs into neural lineage was performed using C. asiatica in the concentration of 400 μg/mL, as prescribed in the previous study (Norazzila et al. 2018) . Before induction, MSCs were seeded at a density of 5 × 10³ cells/cm² in a 6 well plate (Thermo Scientific, Denmark) and cultured for 2 days for attachment. Then, for the experimental group, the cells were cultured in α-MEM LG (Gibco, USA) complete medium supplemented with 400 μg/mL C. asiatica. 
SEEDING OF MSCS AND NDMSCS INTO DECELLULARIZED HUC ARTERY CONDUIT
Arteries were cut approximately 1.5 cm each and MSCs or ndMSCs were seeded into the conduit. Briefly, the cell pellet containing 1.5 × 10 6 of MSCs or ndMSCs were resuspended in 20 μL of FBS and seeded directly into the lumen of the conduit using p200 micropipette (Eppendorf, Germany). The MSCs seeded conduit (MC) or ndMSCs seeded conduit (NC) were then cultured for another 2 days at 37°C in humidified 5% CO 2 incubator to enable cell attachment before conduit implantation.
H&E STAINING OF MSCS SEEDED CONDUIT (MC) AND NDMSCS SEEDED CONDUIT (NC) (PRE-GRAFTING)
After seeding, H&E staining was done to evaluate the MC and NC histological structure before implantation. After 2 days in incubation, the MC or NC was first fixed with 10% formalin for 24 h. The protocol for H&E staining was used as previously discussed.
RESULTS AND DISCUSSION
The efficiency of decellularization process of the human umbilical cord (HUC) arteries and cell seeding attachment play a vital role in developing nerve conduit. This study was performed to analyze the development of nerve conduit using decellularized human umbilical cord (HUC) artery seeded with neurodifferentiated human MSCs (ndMSCs) in bridging peripheral nerve gap. To investigate the effectiveness of a developed nerve conduit, H&E staining, nuclei counterstaining with DAPI, measurement of the length of artery conduit and in vitro evaluation of constructed nerve conduit were performed.
DECELLULARIZATION AND DEVELOPMENT OF THE HUC ARTERY
Freshly isolated HUC were dissected to collect arteries inside (Figure 1(A) ) and directly cleaned from blood and connective tissue (Figure 1(B) ). After various stages of processing, the decellularized HUC arteries did not collapse and the lumen remained rigid (Figure 1(C) ). This could be due to the extracellular matrix (ECM) of the HUC arteries were retained during the decellularization process. There were two arteries reside within HUC while there was only one vein. The HUC arteries have thicker muscular wall compared to HUC veins and it did not have branches. The decellularization process removed all cellular and nuclei material. In this study, the HUC arteries were decellularized with a combination of enzymatic and detergent as it improved decellularization efficiency and retained appropriated extracellular matrix content (Gilpin (Gui et al. 2009 ). Similarly with this study, the HUC arteries has unique criteria of long graft without branches and has similar dimensions with peripheral nerve (TuanMu et al. 2014) . Besides, HUC was not frozen before decellularization as a study reported that the efficiency of decellularization were reduced when frozen HUC were used (Tuan-Mu et al. 2014 ).
HEMATOXYLIN & EOSIN (H&E) STAINING AND NUCLEI COUNTER STAINING WITH DAPI OF DECELLULARIZED HUC ARTERY CONDUIT
The HUC arteries decellularization efficiency was evaluated by staining of the nuclear and cellular components. Previous study stated that the decellularization process that used SDS solution was effective in reducing cellular content. The decellularization process removed immunogenic cells, other soluble components of the matrix and enhanced permeability (Crouzier et al. 2009 ). Another study reported that the extra cellular matrix of collagen fibers was well preserved of a decellularized HUC artery. The decellularized HUC artery minimized immunogenicity, supported cell seeding and could be stored for a long term (Gui et al. 2009 ). In addition, decellularized HUC artery lacking of cellular and nuclear residues thus make it suitable for developing nerve graft (Mallis et al. 2014) . Based on the results of H&E staining and nuclei counterstaining with DAPI in this study, it is concluded that by decellularization process, all residual blood, cells and other soluble components have been successfully removed. This technique is important to prevent any rejection during subsequent implantation in clinical use. After 12 weeks in incubation, the decellularized HUC artery conduit did not degrade and swell. The decellularized HUC artery conduit also did not collapse and the length remained almost the same throughout the whole study. Only a small change (11.8% ± 1.85) was recorded and it is negligible (Figure 3) . Furthermore, the decellularized HUC artery conduit maintained its shape and three-dimensional properties. The maintaining of the length and shape of the decellularized HUC artery conduit could be due to preserved ECM during decellularization process and the thick muscular wall of the artery vessels. Thick muscular wall of the arteries could prevent degradation and muscular infiltration during clinical implantation in the nerve area. A few studies have accumulated the evidence of the good biomechanical strength of decellularized arteries. Consistent with our findings, a study mentioned that decellularized arteries or blood vessels maintained their three dimensional properties (Rodríguez-Rodríguez et al. 2017 ). Besides, their biomechanical strength is better that synthetic materials in both in vitro and in vivo models (Schaner et al. 2004 ). Another investigation demonstrated that decellularization of arteries modified structural and elastic properties of the vessels, however the wall thickness remained the same. To compare with native arteries, decellularized arteries were larger, thinner and stiffer which able to accommodate high pressure before rupturing (Roy et al. 2005) . To point out an ideal nerve conduit, certain criteria need to be fulfilled; sufficient mechanical strength, not easily collapse and presence of tubular lumen for nerve cells to grow.
ISOLATION AND PROPAGATION OF HUMAN WHARTON'S JELLY MSCS (hWJMSCs)
hWJMSCs were successfully isolated using enzymatic digestion from the human umbilical cord sample. The mesenchymal stem cells isolated displayed homogenous, plastic adherence and bipolar spindle shaped morphology in monolayer cultures. In the early passage, the cells demonstrated more fibroblastic like appearance and spindle shaped morphology. Towards later passage, the cells were more enlarged and flattened (Figure 4 ). This could be due to long term in vitro expansion that contributes to cell maturing and aging (Neuhuber et al. 2008; Safwani et al. 2012; Zhuang et al. 2015) . The use of hWJMSCs is said to be a desirable choice compared to other sources of mesenchymal stem cells such as bone marrow or peripheral blood because it is easily available and not a major ethical concern. According to previous study done, these cells possess unique characteristics of both human mesenchymal stem cells and human embryonic stem cells (ESC) based on immunophenotyping analysis. On the other hand, these cells lacked hematopoietic markers. Furthermore, these cells were able to differentiate into trilineage differentiation which is osteogenic, adipogenic and chondrogenic (Lim et al. 2016) . The mentioned criteria, spindle shaped morphology, plastic adherence, express mesenchymal stem cells markers, lacked hematopoietic markers and capability of trilineage differentiation are the minimum criteria for mesenchymal stem cells (Dominici et al. 2006) . Since similar isolation protocol and laboratory environment were being used in this experiment, it is assumed that mesenchymal stem cells isolated in this study possess the same characteristics.
IMMUNOCYTOCHEMISTRY (ICC) ANALYSIS OF NEURODIFFERENTIATED MESENCHYMAL STEM CELLS (ndMSCs)
The capability of mesenchymal stem cells to differentiate into several cells type of mesenchymal origin is well establish. On the other hand, mesenchymal stem cells also have the potential to differentiate into neuroectodermal lineage cells in the presence of neurotrophic factor (Jadalannagari et al. 2015; Wakao et al. 2014) . After treated with 400 μg/mL of C. asiatica, neurodifferentiated mesenchymal stem cells (ndMSCs) showed the expression of S100β, P75 NGFR, MBP and GFAP markers in a similar manner with Schwann cells. As opposed to mesenchymal FIGURE 3. The decellularized HUC artery conduit did not degrade and swell after 12 weeks in incubation. A small change (11.8% ± 1.85) was observed on the decellularized HUC artery conduit stem cells, the only expression observed was in S100β marker, while no expression was observed in P75 NGFR, MBP and GFAP markers ( Figure 5 ). The present findings in this study agreed with earlier study stated that minimal concentration of C. asiatica (400 μg/mL) has the capacity to differentiate hWJMSCs into Schwann cells or other neural lineage cells (Norazzila et al. 2018) .
On the other hand, S100β is a calcium-binding protein concentrated in glial cells, however several studies have reported that this Schwann cells specific marker can be expressed by non-neural cells, such as mesenchymal stem cells, as what has been observed in this study (Deng et al. 2006; Michetti et al. 2012 ). Moreover, a study mentioned that S100β marker is not a very reliable marker for Schwann cells because early culture stage of Schwann cells did not express this marker. Similar study also reported that the expression of various Schwann cells related markers at different time point is necessary for the development of Schwann cells (Liu et al. 2015) . In addition, the ability of C. asiatica to act as a neurotrophic FIGURE 4. Human Wharton's Jelly MSCs from primary culture, passage 0 (P0) until expanded passages, passage 4 (P4), as observed under phase contrast microscope. hWJMSCs demonstrated fibroblastic appearance and spindle shaped morphology in early culture and more flattened shape towards the late passages. Magnification, 10 × Scale bar, 100 μm FIGURE 5. Expression of S100β, P75 NGFR, MBP and GFAP were observed in the neurodifferentiated MSCs (ndMSCs) in a similar manner as Schwann cells. Meanwhile the expression of S100β was observed in MSCs, however the expression of P75 NGFR, MBP and GFAP were not observed in MSCs. The expressions of neural markers after induction of MSCs showed that MSCs were successfully neurodifferentiated by using 400 μg/mL of C. asiatica. Magnification, 10 × Scale bar, 100 μm factor and induced the differentiation of mesenchymal stem cells into neural lineage cells might be attributed to the bioactive compounds present; mainly asiatic acid and madecassid asic (Puttarak et al. 2016 ) that play a major role in the enhancement of neurite outgrowth that happens after differentiation (Jiang et al. 2016; Wanakhachornkrai et al. 2013) .
IN VITRO EVALUATION OF CONSTRUCTED NERVE CONDUIT (PRE-GRAFTING)
An ideal nerve conduit should support recellularization because the seeding of the cells into nerve conduit has been shown to be essential in promoting nerve regeneration (Kaizawa et al. 2017 (Kaizawa et al. , 2016 Shalaby et al. 2017; Xu et al. 2016) . To test whether decellularized HUC artery conduit support recellularization, mesenchymal stem cells and neurodifferentiated mesenchymal stem cells (ndMSCs) were seeded into the luminal surface of the decellularized HUC artery and incubated for 2 days. After 2 days of incubation, H&E staining showed that the mesenchymal stem cells and ndMSCs adhered and spread well in the lumen and surface of the decellularized artery conduit ( Figure 6 ). The seeded mesenchymal stem cells and ndMSCs did not become clump and form aggregation. The decellularized HUC artery conduit retained majority of extracellular matrix and support the cells seeded thus highlighted the good biocompatibility property. The adherence of mesenchymal stem cells and ndMSCs on the vessels wall could be due to extracellular matrix collagen fibers that were preserved during decellularization. Extracellular matrix is an important component for cell adhesion, migration, proliferation and adaptive tissue responses (Badylak et al. 2009 ). Besides, the collagen fibers of an extracellular matrix scaffold play a vital role in determining its biocompatibility and biomechanical properties. As opposed to previous studies that reported about the success of seeding neuronal cell line and human umbilical vein endothelial cells into the decellularized HUC artery for nerve regeneration (Crouzier et al. 2009; Gui et al. 2009) , in this study, the decellularized HUC artery supported the seeding of the mesenchymal stem cells and neurodifferentiated mesenchymal stem cells.
CONCLUSION
In this study, nerve conduit using decellularized HUC artery seeded with neurodifferentiated human MSCs (ndMSCs) was successfully developed. This study showed the potential utility of neurodifferentiated MSCs using C. asiatica for critical size peripheral nerve injury. This technique offers a promising approach in the development of nerve conduit and as an alternative strategy to the treatment of critical nerve defect. However, preclinical study needs to be done to see its effectiveness before it can be applied in clinical trial. 
